NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP
UnitedHealth Group Incorporated UNH
19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY16 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$447.6B
▲ 11.8% vs FY2024
Dividend streak
16 yrs
Raised every year since 2010
EPS · FY25
$13.23
Dividend / sh · FY25
$8.73
Payout · FY25
66%
ROE · FY25
—
Net margin · FY25
2.7%
Dividend coverage
1.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 447.6B
Revenue, FY2025 · full 19-year series below
Revenue
Net income
3 cents of every revenue dollar became profit this year.
Per share
USD 13.23
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 1.5 times — the rest stayed in the company.
Profitability
—
Return on equity, FY2025
ROE
Operating margin4.2%
Net margin2.7%
Return on assets4.0%
Returned to shareholders
USD 12.6B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 7.9B
Net buybacksUSD 4.7B
Share of profit104.8%
Consecutive raises16 years
USD 7.9B in dividends and USD 4.7B in buybacks — 105% of the year's profit, so the payout drew on cash built up earlier.
Growth
+11.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+11.4%
+11.7%
+11.0%
+11.0%
Net income
−15.7%
−4.8%
+7.6%
+6.6%
EPS, diluted
−14.5%
−3.8%
+8.2%
+8.1%
Dividend / share
+10.9%
+12.6%
+16.6%
+22.7%
Returned to shareholders
+2.5%
+11.3%
+17.2%
+10.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.91B
Shares outstanding, FY2025
Change, 5 years−4.2%
Change, 10 years−4.9%
The share count shrank 4% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 309.6B
total assets, end of FY2025
Total assetsUSD 309.6B
CashUSD 24.4B
Gross debtUSD 78.4B
Net debtUSD 54.0B
Current ratio0.79×
History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
447.6
400.3
371.6
324.2
287.6
257.1
242.2
226.2
201.2
184.8
157.1
130.5
122.5
110.6
101.9
94.2
87.1
81.2
75.4
Operating income $B
19.0
32.3
32.4
28.4
24.0
22.4
19.7
17.3
15.2
12.9
11.0
10.3
9.6
9.3
8.5
7.9
6.4
5.3
7.8
EBITDA $B
20.0
33.3
33.5
29.5
25.0
23.4
20.7
18.3
16.0
13.6
11.6
10.8
10.1
9.7
8.8
8.3
6.8
·
·
Income tax $B
1.9
4.8
6.0
5.7
4.6
5.0
3.7
3.6
3.2
4.8
4.4
4.0
3.2
3.1
2.8
2.7
2.0
1.6
2.7
Net income $B
12.1
14.4
22.4
20.1
17.3
15.4
13.8
12.0
10.6
7.0
5.8
5.6
5.6
5.5
5.1
4.6
3.8
3.0
4.7
EPS, diluted $
13.23
15.51
23.86
21.18
18.08
16.03
14.33
12.19
10.72
7.25
6.01
5.70
5.50
5.28
4.73
4.10
3.24
2.40
3.42
Dividend / sh $
8.73
8.18
7.29
6.40
5.60
4.83
4.14
3.45
2.88
2.38
1.88
1.41
1.05
0.80
0.61
0.41
0.03
0.03
0.03
Payout %
66
52
30
30
31
30
28
28
26
32
31
24
19
15
13
10
1
1
1
ROE %
·
·
·
·
·
·
·
·
·
·
17.9
17.4
17.8
18.6
19.0
18.7
17.2
14.6
23.2
Shares out B
0.91
0.92
0.92
0.93
0.94
0.95
0.95
0.96
0.97
0.95
0.95
0.95
0.99
1.02
1.04
1.09
1.15
1.20
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
55 of 55
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed